2018 annual financial data
Voyager Therapeutics 2018 Operating margin
Direct answer
Operating margin was -1,195.63%.
Operating income was -91,095,000 USD and net income was -88,288,000 USD.
Operating cash flow was -15,887,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,619,000 USD
- Operating income
- -91,095,000 USD
- Net income
- -88,288,000 USD
- Operating cash flow
- -15,887,000 USD